We also treated NUCB2 knockdown the breast cancer cell lines with purified Nesfatin-1 and found that the expression of SREBP2 and HMGCR was upregulated in a dose-dependent manner (Fig. 6B). This evidence concerns the gene NUCB2 and breast carcinoma.